These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 724319

  • 21. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management.
    Mahasandana C, Patharathienskul D, Suvatte V.
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():106-12. PubMed ID: 7886549
    [Abstract] [Full Text] [Related]

  • 22. Use of prothrombin complex concentrates in the treatment of a hemophilic patient with an inhibitor of factor VIII.
    Sonoda T, Solomon A, Krauss S, Cruz P, Jones FS, Levin J.
    Blood; 1976 Jun; 47(6):983-9. PubMed ID: 1276480
    [Abstract] [Full Text] [Related]

  • 23. [Substitution therapy with prothrombin complex concentrates in acquired coagulation disorders].
    Fischer M.
    Wien Klin Wochenschr; 1983 Feb 04; 95(3):82-5. PubMed ID: 6858171
    [Abstract] [Full Text] [Related]

  • 24. Early experience with the use of anti-inhibitor coagulant complex to treat bleeding in hemophiliacs with inhibitors to factor VIII.
    Kantrowitz JL, Lee ML, McClure DA, Kingdon HS, Thomas WR.
    Clin Ther; 1987 Feb 04; 9(4):405-19. PubMed ID: 3111706
    [Abstract] [Full Text] [Related]

  • 25. Treatment of hemophilia complicated by inhibitors.
    Scand J Haematol Suppl; 1980 Feb 04; 35():135-64. PubMed ID: 6770458
    [No Abstract] [Full Text] [Related]

  • 26. [The problem of factor VIII inhibitors in patients with congenital coagulopathies].
    Klare M.
    Z Gesamte Inn Med; 1983 Jan 15; 38(2):47-50. PubMed ID: 6407220
    [Abstract] [Full Text] [Related]

  • 27. [Outcome of hemorrhage treatment in children with hemophilia A related to factor VIII inhibitor].
    Klukowska A, Zieleniewska B.
    Acta Haematol Pol; 1994 Jan 15; 25(4):349-54. PubMed ID: 7847036
    [Abstract] [Full Text] [Related]

  • 28. Letter: Treatment of inhibitors to factor VIII with activated prothrombin concentrate.
    Sultan Y, Brouet JC, Debre P.
    N Engl J Med; 1974 Nov 14; 291(20):1087. PubMed ID: 4414451
    [No Abstract] [Full Text] [Related]

  • 29. Prothrombin complex concentrates. Use in treatment of hemophiliacs with factor VIII inhibitors.
    Yolken RH, Hilgartner MW.
    Am J Dis Child; 1978 Mar 14; 132(3):291-3. PubMed ID: 629247
    [Abstract] [Full Text] [Related]

  • 30. Activated factor IX complex in treatment of surgical cases of hemophilia A with inhibitors.
    Hanna WT, Madigan RR, Miles MA, Lange RD.
    Thromb Haemost; 1981 Oct 14; 46(3):638-41. PubMed ID: 6976016
    [Abstract] [Full Text] [Related]

  • 31. Inhibitor treatment using unactivated prothrombin complex concentrates: the Pennsylvania experience--1978-1982.
    Eyster ME, Spero JA, Catalano PM, Gill FM, Lusch CJ, Kajani MK, Barron LE, DeGreen HP, Shapiro SS, Lewis JH.
    Prog Clin Biol Res; 1984 Oct 14; 150():309-22. PubMed ID: 6431435
    [Abstract] [Full Text] [Related]

  • 32. Treatment of anti-factor VIII antibodies.
    Blatt PM, White GC, McMillan CW, Roberts HR.
    Thromb Haemost; 1977 Aug 31; 38(2):514-23. PubMed ID: 579493
    [Abstract] [Full Text] [Related]

  • 33. [Importance of PPSB fraction in the treatment of hemophilia A with antibodies against factor VIII].
    Hrubisková K.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1980 Aug 31; 107(4):672-82. PubMed ID: 6162735
    [Abstract] [Full Text] [Related]

  • 34. In vitro evaluation of factor VIII--bypassing activity of activated prothrombin complex concentrate, prothrombin complex concentrate, and factor VIIa in the plasma of patients with factor VIII inhibitors: thrombin generation test in the presence of collagen-activated platelets.
    Sultan Y, Loyer F.
    J Lab Clin Med; 1993 Mar 31; 121(3):444-52. PubMed ID: 8445292
    [Abstract] [Full Text] [Related]

  • 35. [Emergency treatment of haemophilia A with factor VIII inhibitors using activated prothrombin complex concentrates (author's transl)].
    Rasche H, Bindewald H, Köhle W, Scheck R, Heinrich R, Seibert K.
    Dtsch Med Wochenschr; 1977 Mar 04; 102(9):319-23. PubMed ID: 300053
    [Abstract] [Full Text] [Related]

  • 36. [Development of factor VIII inhibitor in three non-hemophiliac patients].
    Kiguchi T, Niiya K, Yamawaki Y, Shima M, Harada M.
    Rinsho Ketsueki; 2000 Nov 04; 41(11):1195-200. PubMed ID: 11193439
    [Abstract] [Full Text] [Related]

  • 37. Laboratory identification of factor inhibitors: an update.
    Kershaw G, Favaloro EJ.
    Pathology; 2012 Jun 04; 44(4):293-302. PubMed ID: 22531341
    [Abstract] [Full Text] [Related]

  • 38. A retrospective study of Octaplex in the treatment of bleeding in patients with haemophilia A complicated by inhibitors.
    Berntorp E, Figueiredo S, Futema L, Pock K, Knaub S, Walter O, Trawnicek L, Römisch J.
    Blood Coagul Fibrinolysis; 2010 Sep 04; 21(6):577-83. PubMed ID: 20644466
    [Abstract] [Full Text] [Related]

  • 39. Clinical efficacy of prothrombin complex concentrates and recombinant factor VIIa in the treatment of bleeding episodes in patients with factor VII and IX inhibitors.
    Barthels M.
    Thromb Res; 1999 Aug 15; 95(4 Suppl 1):S31-8. PubMed ID: 10499907
    [Abstract] [Full Text] [Related]

  • 40. The use of non-activated prothrombin concentrate in the management of haemophilia A with factor VIII antibodies.
    Price DA, d'Souza S, Ekert H.
    Aust N Z J Med; 1977 Jun 15; 7(3):286-90. PubMed ID: 269689
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.